Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany
- PMID: 20169297
- DOI: 10.2340/00015555-0770
Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany
Abstract
Epidemiological studies indicate an increased risk of co-morbidities and an association with other inflammatory diseases in psoriasis. However, most analyses have been performed on small samples of patients. The aim of this study was to evaluate the prevalence of co-morbidities in psoriasis based on a large set of health insurance data. The database of 1.3 million patients in a German nationwide statutory health insurance scheme was analysed. Data-sets of patients with confirmed psoriasis were extracted and analysed for co-morbidities. Of 1,344,071 subjects, 33,981 had a diagnosis of psoriasis (prevalence 2.5%). Metabolic syndrome was 2.9-fold more frequent among these patients. The most common diagnoses were arterial hypertension (35.6% in psoriasis vs. 20.6% in controls) and hyperlipidaemia (29.9% vs. 17.1%). The frequencies of rheumatoid arthritis (prevalence ratio (PR) 3.8), Crohn's disease (PR 2.1) and ulcerative colitis (PR 2.0) were also increased among patients with psoriasis. In conclusion, psoriasis is associated with significant co-morbidities that imply an elevated risk of severe complications.
Similar articles
-
Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.G Ital Dermatol Venereol. 2011 Feb;146(1):31-45. G Ital Dermatol Venereol. 2011. PMID: 21317855 Review.
-
Prevalence of metabolic syndrome in patients with psoriasis.Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):662-5. doi: 10.4103/0378-6323.72462. Indian J Dermatol Venereol Leprol. 2010. PMID: 21079309
-
Psoriasis, the liver, and the gastrointestinal tract.Dermatol Ther. 2010 Mar-Apr;23(2):155-9. doi: 10.1111/j.1529-8019.2010.01310.x. Dermatol Ther. 2010. PMID: 20415823 Review.
-
Epidemiology and comorbidity of psoriasis in children.Br J Dermatol. 2010 Mar;162(3):633-6. doi: 10.1111/j.1365-2133.2009.09593.x. Epub 2009 Nov 18. Br J Dermatol. 2010. PMID: 19922529
-
The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.J Am Acad Dermatol. 2009 Sep;61(3):405-10. doi: 10.1016/j.jaad.2009.02.015. J Am Acad Dermatol. 2009. PMID: 19700012
Cited by
-
Effects of a Brief Mindfulness-based Intervention in Patients with Psoriasis: A Randomized Controlled Trial.Acta Derm Venereol. 2024 Apr 19;104:adv18277. doi: 10.2340/actadv.v104.18277. Acta Derm Venereol. 2024. PMID: 38639157 Free PMC article. Clinical Trial.
-
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State.Dermatol Ther (Heidelb). 2024 Mar;14(3):767-775. doi: 10.1007/s13555-024-01126-y. Epub 2024 Mar 7. Dermatol Ther (Heidelb). 2024. PMID: 38451420 Free PMC article.
-
Downregulation of Caveolae-Associated Proteins in Psoriasis: A Case Series Study.JID Innov. 2024 Feb 1;4(2):100265. doi: 10.1016/j.xjidi.2024.100265. eCollection 2024 Mar. JID Innov. 2024. PMID: 38445230 Free PMC article.
-
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands.Adv Ther. 2024 Apr;41(4):1594-1605. doi: 10.1007/s12325-023-02759-9. Epub 2024 Feb 24. Adv Ther. 2024. PMID: 38402373
-
A Bibliometric Analysis of Global Research Trends in Psoriasis and Metabolic Syndrome.Clin Cosmet Investig Dermatol. 2024 Feb 9;17:365-382. doi: 10.2147/CCID.S446966. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38352064 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials